List of Tables
Table 1. Pneumococcal Vaccines Market Segments
Table 2. Ranking of Global Top Pneumococcal Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pneumococcal Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of PPSV 23
Table 5. Major Manufacturers of PCV 7/13
Table 6. Major Manufacturers of PCV 10
Table 7. Global Pneumococcal Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Pneumococcal Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Pneumococcal Vaccines Sales by Regions 2015-2020 (K Units)
Table 10. Global Pneumococcal Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global Pneumococcal Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Pneumococcal Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Pneumococcal Vaccines Sales Share by Manufacturers (2015-2020)
Table 14. Global Pneumococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Pneumococcal Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccines as of 2019)
Table 16. Pneumococcal Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Pneumococcal Vaccines Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Pneumococcal Vaccines Price (2015-2020) (USD/Unit)
Table 19. Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Pneumococcal Vaccines Product Type
Table 21. Date of International Manufacturers Enter into Pneumococcal Vaccines Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 24. Global Pneumococcal Vaccines Sales Share by Type (2015-2020)
Table 25. Global Pneumococcal Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Pneumococcal Vaccines Revenue Share by Type (2015-2020)
Table 27. Pneumococcal Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 29. Global Pneumococcal Vaccines Sales Share by Application (2015-2020)
Table 30. North America Pneumococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 31. North America Pneumococcal Vaccines Sales Market Share by Country (2015-2020)
Table 32. North America Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Pneumococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 34. North America Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 35. North America Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Table 36. North America Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 37. North America Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Table 38. Europe Pneumococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 39. Europe Pneumococcal Vaccines Sales Market Share by Country (2015-2020)
Table 40. Europe Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Pneumococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 42. Europe Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 43. Europe Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Table 44. Europe Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 45. Europe Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Pneumococcal Vaccines Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Pneumococcal Vaccines Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Pneumococcal Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Pneumococcal Vaccines Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Table 54. Latin America Pneumococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 55. Latin America Pneumococcal Vaccines Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Pneumococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 58. Latin America Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 59. Latin America Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Table 60. Latin America Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 61. Latin America Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Pneumococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Pneumococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Major Businesses
Table 72. Pfizer Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Pfizer Product
Table 74. Pfizer Recent Development
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Major Businesses
Table 77. Sanofi Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Sanofi Product
Table 79. Sanofi Recent Development
Table 80. GSK Corporation Information
Table 81. GSK Description and Major Businesses
Table 82. GSK Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GSK Product
Table 84. GSK Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Major Businesses
Table 87. Merck Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Merck Product
Table 89. Merck Recent Development
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Major Businesses
Table 92. Eli Lilly Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Eli Lilly Product
Table 94. Eli Lilly Recent Development
Table 95. AstraZeneca Corporation Information
Table 96. AstraZeneca Description and Major Businesses
Table 97. AstraZeneca Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. AstraZeneca Product
Table 99. AstraZeneca Recent Development
Table 100. Abera Corporation Information
Table 101. Abera Description and Major Businesses
Table 102. Abera Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Abera Product
Table 104. Abera Recent Development
Table 105. S K Chemicals Corporation Information
Table 106. S K Chemicals Description and Major Businesses
Table 107. S K Chemicals Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. S K Chemicals Product
Table 109. S K Chemicals Recent Development
Table 110. Beijing Minhai Biotechnology Corporation Information
Table 111. Beijing Minhai Biotechnology Description and Major Businesses
Table 112. Beijing Minhai Biotechnology Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Beijing Minhai Biotechnology Product
Table 114. Beijing Minhai Biotechnology Recent Development
Table 115. Baxter Corporation Information
Table 116. Baxter Description and Major Businesses
Table 117. Baxter Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Baxter Product
Table 119. Baxter Recent Development
Table 120. Biken Corporation Information
Table 121. Biken Description and Major Businesses
Table 122. Biken Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Biken Product
Table 124. Biken Recent Development
Table 125. Celgene Corporation Corporation Information
Table 126. Celgene Corporation Description and Major Businesses
Table 127. Celgene Corporation Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Celgene Corporation Product
Table 129. Celgene Corporation Recent Development
Table 130. Panacea Biotec Corporation Information
Table 131. Panacea Biotec Description and Major Businesses
Table 132. Panacea Biotec Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Panacea Biotec Product
Table 134. Panacea Biotec Recent Development
Table 135. Serum Institute of India Corporation Information
Table 136. Serum Institute of India Description and Major Businesses
Table 137. Serum Institute of India Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Serum Institute of India Product
Table 139. Serum Institute of India Recent Development
Table 140. Genentech Corporation Information
Table 141. Genentech Description and Major Businesses
Table 142. Genentech Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Genentech Product
Table 144. Genentech Recent Development
Table 145. Genocea Biosciences Corporation Information
Table 146. Genocea Biosciences Description and Major Businesses
Table 147. Genocea Biosciences Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Genocea Biosciences Product
Table 149. Genocea Biosciences Recent Development
Table 150. ImmunoBiology Corporation Information
Table 151. ImmunoBiology Description and Major Businesses
Table 152. ImmunoBiology Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. ImmunoBiology Product
Table 154. ImmunoBiology Recent Development
Table 155. Lupin Corporation Information
Table 156. Lupin Description and Major Businesses
Table 157. Lupin Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Lupin Product
Table 159. Lupin Recent Development
Table 160. Nuron Biotech Corporation Information
Table 161. Nuron Biotech Description and Major Businesses
Table 162. Nuron Biotech Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. Nuron Biotech Product
Table 164. Nuron Biotech Recent Development
Table 165. Biogen Corporation Information
Table 166. Biogen Description and Major Businesses
Table 167. Biogen Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. Biogen Product
Table 169. Biogen Recent Development
Table 170. Valneva Austria Corporation Information
Table 171. Valneva Austria Description and Major Businesses
Table 172. Valneva Austria Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 173. Valneva Austria Product
Table 174. Valneva Austria Recent Development
Table 175. Sinovac Corporation Information
Table 176. Sinovac Description and Major Businesses
Table 177. Sinovac Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 178. Sinovac Product
Table 179. Sinovac Recent Development
Table 180. Global Pneumococcal Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 181. Global Pneumococcal Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 182. Global Pneumococcal Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 183. Global Pneumococcal Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 184. North America: Pneumococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 185. North America: Pneumococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 186. Europe: Pneumococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 187. Europe: Pneumococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 188. Asia Pacific: Pneumococcal Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 189. Asia Pacific: Pneumococcal Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 190. Latin America: Pneumococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 191. Latin America: Pneumococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 192. Middle East and Africa: Pneumococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 193. Middle East and Africa: Pneumococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 194. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 195. Key Challenges
Table 196. Market Risks
Table 197. Main Points Interviewed from Key Pneumococcal Vaccines Players
Table 198. Pneumococcal Vaccines Customers List
Table 199. Pneumococcal Vaccines Distributors List
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Vaccines Product Picture
Figure 2. Global Pneumococcal Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. PPSV 23 Product Picture
Figure 4. PCV 7/13 Product Picture
Figure 5. PCV 10 Product Picture
Figure 6. Global Pneumococcal Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. For Infants
Figure 8. For Children (2-10)
Figure 9. For Person (10-64)
Figure 10. For The Old (Above 65)
Figure 11. Pneumococcal Vaccines Report Years Considered
Figure 12. Global Pneumococcal Vaccines Market Size 2015-2026 (US$ Million)
Figure 13. Global Pneumococcal Vaccines Sales 2015-2026 (K Units)
Figure 14. Global Pneumococcal Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Pneumococcal Vaccines Sales Market Share by Region (2015-2020)
Figure 16. Global Pneumococcal Vaccines Sales Market Share by Region in 2019
Figure 17. Global Pneumococcal Vaccines Revenue Market Share by Region (2015-2020)
Figure 18. Global Pneumococcal Vaccines Revenue Market Share by Region in 2019
Figure 19. Global Pneumococcal Vaccines Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Pneumococcal Vaccines Revenue in 2019
Figure 21. Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Figure 23. Global Pneumococcal Vaccines Sales Market Share by Type in 2019
Figure 24. Global Pneumococcal Vaccines Revenue Market Share by Type (2015-2020)
Figure 25. Global Pneumococcal Vaccines Revenue Market Share by Type in 2019
Figure 26. Global Pneumococcal Vaccines Market Share by Price Range (2015-2020)
Figure 27. Global Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Figure 28. Global Pneumococcal Vaccines Sales Market Share by Application in 2019
Figure 29. Global Pneumococcal Vaccines Revenue Market Share by Application (2015-2020)
Figure 30. Global Pneumococcal Vaccines Revenue Market Share by Application in 2019
Figure 31. North America Pneumococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Pneumococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Pneumococcal Vaccines Sales Market Share by Country in 2019
Figure 34. North America Pneumococcal Vaccines Revenue Market Share by Country in 2019
Figure 35. U.S. Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Pneumococcal Vaccines Market Share by Type in 2019
Figure 40. North America Pneumococcal Vaccines Market Share by Application in 2019
Figure 41. Europe Pneumococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Pneumococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Pneumococcal Vaccines Sales Market Share by Country in 2019
Figure 44. Europe Pneumococcal Vaccines Revenue Market Share by Country in 2019
Figure 45. Germany Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Pneumococcal Vaccines Market Share by Type in 2019
Figure 56. Europe Pneumococcal Vaccines Market Share by Application in 2019
Figure 57. Asia Pacific Pneumococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Pneumococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Pneumococcal Vaccines Sales Market Share by Region in 2019
Figure 60. Asia Pacific Pneumococcal Vaccines Revenue Market Share by Region in 2019
Figure 61. China Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Pneumococcal Vaccines Market Share by Type in 2019
Figure 84. Asia Pacific Pneumococcal Vaccines Market Share by Application in 2019
Figure 85. Latin America Pneumococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Pneumococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Pneumococcal Vaccines Sales Market Share by Country in 2019
Figure 88. Latin America Pneumococcal Vaccines Revenue Market Share by Country in 2019
Figure 89. Mexico Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Pneumococcal Vaccines Market Share by Type in 2019
Figure 96. Latin America Pneumococcal Vaccines Market Share by Application in 2019
Figure 97. Middle East and Africa Pneumococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Pneumococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Pneumococcal Vaccines Revenue Market Share by Country in 2019
Figure 101. Turkey Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Pneumococcal Vaccines Market Share by Type in 2019
Figure 108. Middle East and Africa Pneumococcal Vaccines Market Share by Application in 2019
Figure 109. North America Pneumococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Pneumococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Pneumococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Pneumococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Pneumococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Pneumococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Pneumococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Pneumococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Pneumococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Pneumococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
